Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical CystectomyShingo Hatakeyama, Takeshi Sano, Fumihiko Urabe et al.|Cancer Medicine|2025Cited by 8
Stage <scp>III</scp> substaging and outcomes in patients with bladder cancer undergoing radical cystectomyShuhei Hara, Wataru Fukuokaya, Jun Miki et al.|International Journal of Urology|2025Cited by 7
Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohortRyoichi Saito, Rikiya Taoka, Jun Miki et al.|International Journal of Clinical Oncology|2025Cited by 5
Prognostic impact of histological discordance between transurethral resection and radical cystectomyAyumu Matsuda, Rikiya Taoka, Jun Miki et al.|British Journal of Urology|2024Cited by 4
Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi‐institutional studyJun Miki, Wataru Fukuokaya, Rikiya Taoka et al.|International Journal of Urology|2024Cited by 4